Professional Documents
Culture Documents
DEVEZA)
OUTLINE
β- lactam antibiotics Other antibiotics
1. Inhibitors of Cell Wall Synthesis
Penicillins Bacitracin
2. Protein Synthesis Inhibitors
Cephalosporins Vancomycin
3. Inhibitors of Folic Acid Synthesis
Carbapenems
4. Inhibitors of Nucleic Acid Synthesis
Monobactam
- Interstitial nephritis
(methicillin)
DEFINITION OF TERMS
- Maculopapular rash
o Chemotherapy: The use of drugs to treat a disease.
(ampicillin)
o Antimicrobial drugs: Interfere with the growth of
microbes within a host.
2. Cephalosporins
o Antibiotic: Substance produced by a microbe that, in small
MOA & MOR: Same as penicillin
amounts, inhibits another microbe.
Adverse Effects:
o Selective toxicity: A drug that kills harmful microbes without
o Hypersensitivity (2%)
damaging the host.
o IV injections - phlebitis
o IM - pain
Background
1928- Fleming discovered penicillin, produced by Penicillium.
1ST GENERATION CEPHALOSPORINS
1940- Howard Florey and Ernst Chain performed first clinical trials of
penicillin. Cephalothin
Mechanism of Action of Penicillin Cephapirin •Effective: Gram (+) cocci
o Inhibits bacterial growth by interfering with the Cephradine •Not MRSA
transpeptidation reaction of bacterial cell wall synthesis. Cephalexin •DO NOT enter CNS
Cefazolin
Cefadroxil
2ND GENERATION CEPHALOSPORINS
Cefamandole • Effective: Gram (-) and
Cefuroxime Anaerobes
Cefonicid • DO NOT enter CNS
Ceforanide
Cefaclor
Cefoxitin
Cefotetan
Cefprozil
Cefmetazole
3RD GENERATION CEPHALOSPORINS
Cefotaxime • Effective: Gram (+)/ (-)
INHIBITORS OF CELL WALL SYNTHESIS Cefixime cocci, Gram (-) rods
1. Penicillins Cefpodoxime • Most enter CNS (not
o Penicillin G o Cloxacillin Cefoperazone cefoperazone)
o Penicillin V o Ampicillin Cefdinir
o Methicillin o Amoxicillin Ceftizoxime
o Nafcillin o Carbenicillin Ceftriaxone
o Oxacillin o Ticarcillin Ceftazidime
Ceftibuten
Mechanism of Action - 1st step: Binds to Penicillin- Cefditoren (new)
Binding Proteins (PBPs). 4TH GENERATION CEPHALOSPORINS
- 2nd step: Inhibits activity of
Cefepime •Broad-spectrum
transpeptidases enzyme
Cefpirome – outside US •Resistant to most Beta-
cross-linking of peptidoglycan
lactamases
chains.
5TH GENERATION CEPHALOSPORINS
- 3rd step: Activate autolysin
Mechanism of Resistance - Penicillinases (β-lactamases) Ceftaroline •MRSA
break lactam ring structure Ceftobiprole •Less on P. aeruginosa,
(e.g. Staphylococci). Acinetobacter, ESBL,
- Structural change PBPs Enterobacteriaceae
- Change in porin structure
Adverse Effects - Hypersensitivity: most
common (5-7%)
- GI distress
- Jarisch-Herxheimer reaction
5. Vancomycin
MOA
o Binding at the D-ala pentapeptide to sterically hinder the
transglycosylation reactions involved in elongation of
peptidoglycan chains.
Coverage
o MRSA (DOC); Gram (+) cocci Enterococci
3. Chloramphenicol
o Anaerobe Clostridium difficile (back-up drug)
- 50s
Adverse Effects
- Inhibit the activity of peptidyltransferase (static)
o Ototoxicity
- Blocks attachment of amino acids to the nascent
o Hypotension
- Adverse Effectcs: “Gray-baby” syndrome (Pale or blue
o Diffuse hyperemia (“red-man syndrome”)
skin, lethargic eyes).
PROTEIN SYNTHESIS INHIBITORS
4. Macrolides
-Inhibit translocation of peptidyl-tRNA (static)
1. Tetracyclines -Erythromycin, Azithromycin, Clarithromycin,
- 30s Roxithromycin
Block the attachment of aminoacyl tRNA to acceptor site 5. Lincosomides
(static). - Clindamycin & Lincomycin
- Prevent interaction of new amino acids to the nascent - Mechanism of Action: same as macrolides
peptide chain - Clindamycin: First known drug to cause
- Coverage: Susceptible G (+) & (-) pseudomembranous colitis
- Adverse Effect: Discoloration of teeth (not recommended
in fetus and < 6 years)
- Doxycycline; Minocycline; Demeclocycline
- DOC against Rickettsiae, Chlamydia and Mycoplasma
pneumoniae